Building effective multilevel HIV prevention partnerships with Black men who have sex with men: experience from HPTN 073, a pre‐exposure prophylaxis study in three US cities
Lisa Hightow‐Weidman(University of North Carolina at Chapel Hill), LaRon E. Nelson(Yale University), Christopher Chauncey Watson(Carilion Clinic), Leo Wilton(Binghamton University), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Sheldon D. Fields(Pennsylvania State University), Steven Shoptaw(University of California, Los Angeles), Geetha Beauchamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jonathan Lucas(Family Health International 360), Manya Magnus(Milken Institute), Ying Qing Chen(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig S Hutchinson, Irene Kuo(George Washington University), Christopher Hucks‐Ortiz(John Wesley Community Health Institute), Darrell P. Wheeler(Loyola University Chicago), Kenneth H. Mayer(Miriam Hospital)
Cited by 0
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891